This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Sanofi: Annual General Shareholder Meeting Of May 5, 2014

  • Shareholder approval of the financial statements for 2013
  • Dividend of €2.80 per share payable as of May 15, 2014
  • Board Composition: election of all proposed Directors

PARIS, May 5, 2014 (GLOBE NEWSWIRE) -- Sanofi (EURONEXT: SAN and NYSE: SNY) announced its Annual General Shareholder Meeting was held today at the Palais des Congrès in Paris. All resolutions were adopted by its shareholders. During the meeting, shareholders approved, among other resolutions, the individual Company and consolidated financial statements for the year 2013. At the General Meeting, shareholders decided the distribution of a cash dividend in the amount of €2.80 per share which will be detached on Euronext Paris on May 12, 2014 with payment as of May 15, 2014.

The General Meeting also elected Patrick Kron as Director and renewed as Directors Christopher Viehbacher, Robert Castaigne and Christian Mulliez, for a term of four years, i.e., until the General Meeting called to approve the financial statements for the year 2017. Lord Douro, whose term of office has expired, did not express the desire to have his mandate renewed.

After the General Meeting, the new Board of Directors is comprised of 16 members, of whom four are women and eleven are independent Directors. It consists of the following members:
  • Serge Weinberg*, Chairman of the Board of Directors
  • Christopher Viehbacher, Chief Executive Officer
  • Laurent Attal
  • Uwe Bicker *
  • Robert Castaigne *
  • Thierry Desmarest
  • Jean-René Fourtou  *
  • Claudie Haigneré *
  • Patrick Kron*
  • Igor Landau
  • Fabienne Lecorvaisier *
  • Suet-Fern Lee *
  • Christian Mulliez
  • Carole Piwnica *
  • Klaus Pohle *
  • Gérard Van Kemmel *

The voting results will be available on the Company's website ( ) in the coming days.

The audiocast of the Annual General Shareholder Meeting is available on the Company's website ( ).

About Sanofi

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY) .
Media Relations  Investor Relations
Gregory Miley  Sébastien Martel
+ (33) 1 53 77 46 46  + (33) 1 53 77 45 45

Link to PDF of Press Release


Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.21 -0.44%
FB $117.80 -0.22%
GOOG $701.26 0.80%
TSLA $211.34 -5.00%
YHOO $36.94 2.60%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs